Center News - Washington National Primate Research Center

Why I Work in Animal Research

This Guest Director’s Blog is by Mark Walton, PhD.
He is a senior research scientist at WaNPRC in the Neuroscience core. We welcomed his timely thoughts in a climate in which it’s valuable to understand the importance of animal research in advancing human and animal health.

In January of 2002, my first child, a son, was born. When he was still only minutes old, the doctor handed me our newborn child and said, “Here’s your son.” The joy I felt in that moment was beyond description, and I couldn’t help speculating about what the future would hold. What sort of life would he lead? Would I be up to the task of preparing this utterly helpless person for the independence of adulthood? I desperately hoped that he would one day find a career path that he would find fulfilling. I thought, too, about the fact that this newly arrived human being that had been entrusted to our care would likely outlive us by at least a couple of decades. I hoped that he would one day find love so that he would always have a family that he could trust.

As I held him in my arms for the first time, I could see that his skin had a bluish tint, but I wasn’t worried at first. We had been warned that newborn babies often take a little while to get their natural color, as their delicate little lungs begin to supply oxygen for the first time. I was so engrossed in the tiny miracle that rested in my arms that I failed to notice the growing concern that must have shown on the faces of the medical professionals that surrounded me. My own concern began to grow slowly, an empty feeling in my gut as I waited for the bluish tint to his skin to turn pink. Instead, his color worsened until a nurse gently took him from me. Soon a doctor explained to me that our son was having trouble breathing because his lungs were not as mature as they should have been. My wife and I were told that he had been taken to the neonatal intensive care unit (NICU), where they would help him to breathe. The technical term for this is respiratory distress syndrome.

That night my wife and I somehow managed to get to sleep. In the morning, the doctor told us that our baby had a “rough night.” She explained that normal lungs produce something called surfactant, which essentially keeps the lungs from sticking together when we exhale. To understand the need for surfactant she asked us to imagine trying to inflate a balloon that was wet on the inside. Our baby’s lungs, she said, were not mature enough to produce the surfactant that he needed. During the night, when he tried to inhale, one of his lungs stuck together. This ripped a hole in the lung, which caused it to collapse.

I listened, doing my best to show a strength that I didn’t feel. I knew this would be even worse for my wife, who was listening to the same horror story after giving birth to a baby. After the doctor finished, I stepped out into the hallway. The moment the door closed the fear that I had so carefully hidden came pouring out like flood water from a collapsed dam. In the hallway of the maternity ward – which should have been filled with joy – I sank to the floor, unable to stand. I wondered if our son was going to die without being held by his mother even once. I must have been quite a sight: a six-foot-three man crying uncontrollably on the floor while new parents walked past me with their healthy babies.

Later that morning, my wife and I were told that we could go to see our son. The doctor led us to the NICU but paused before opening the door. “I need to tell you what you are going to see,” she said. “Your son has a little ‘boo-boo’.” She used those words to describe what turned out to be a hole in our baby’s chest, into which a tube had been inserted. I remember watching the little drops of our child’s blood moving back and forth inside the semi-transparent tubing.

I couldn’t help wondering what our tiny son, just one day old, thought of the world that he’d entered. To him, it must surely be a place of endless pain and suffering. He hadn’t known comfort or love, except for those few precious minutes, in my arms. I would have done anything – even volunteered to be tortured to death – to take away his suffering and heal him.

In the days that followed, our son received an artificial surfactant, developed through years of research. It worked like a miracle. Soon, we were able to bring him home. That was 2002. Today he is a college student with a brilliant mind, studying astrophysics. He got married last summer, and I can honestly say that I have never seen a happier couple.

This miracle happened because of decades of animal research. Thanks to this research, scientists and medical doctors know a lot about how lungs work. Some of the most important work was done by studying pig lungs – experiments that could not have been performed on humans. Thanks to medical research involving animals, scientists learned the crucial role that surfactants play, and they learned how to make the artificial version that saved our son’s life. Before trying it on human babies, scientists first tested it on prematurely born monkeys. All medical treatments undergo this critical phase of testing, ensuring that new treatments are safe before they are given to humans – or, more personally, our children.

In 1963, President John F Kennedy’s newborn son tragically died of the very same problem that nearly killed our son. At that time, medical science had not advanced enough to save him. Medical research, including research involving monkeys, is the only reason that our son survived. For us, this is not a political issue; it is the difference between life and death. Yet as I write this, countless other families are not so fortunate. At this very moment, thousands of parents are watching helplessly as their children suffer and die of diseases that we have yet to treat. For them, the horror that I felt for a few short days will become an emotional wound that never heals.

It’s normal in a democracy for well-meaning, patriotic people to disagree about many things. The need to spare our fellow human beings the indescribable horror of losing a loved one should not be one of them. If there is one thing that we all should agree on, it is that we must support medical research. Every single person reading these words should remember that one day it might be your life that hangs in the balance, or the life of someone that you love. It is my great hope that we continue to support medical research so that an effective treatment will be found before that day comes for your family.

Orsborn Paper: Neural Information Could Impact Brain-Computer Interfaces

Neuroscience core scientist Amy Orsborn published a new paper in the high-impact publication Nature Neuroscience in which she, as lead author, reports that, “Neural populations are dynamic but constrained,” as the title reads.

“Our brains evolved to help us rapidly learn new things. But anyone who has put in hours of practice to perfect their tennis serve, only to reach a plateau, can attest that our brains aren’t infinitely flexible,” the paper begins. “New work shows that patterns of neural activity over time — the temporal dynamics of neural populations — cannot change rapidly, suggesting that neural activity dynamics may both reflect and constrain how the brain performs computations.”

The findings, Dr Orsborn says, has the potential to impact how brain-computer interfaces are developed that could help provide people the use of artificial limbs.

In the study, Orsborn and her colleagues used micro- electrocorticography recordings in two male monkeys to map how their eye movements related to their arm movements. The upshot is the movements mapped in the brain across different regions, which advances our understanding of how our brain works when we do everyday tasks like reaching toward things we’re not looking directly at.

“These insights…reveal opportunities to leverage these signals to enhance future brain-computer interfaces,” she writes.

Dr Orsborn is one of three University of Washington faculty members who recently received fellowships from the Alfred P. Sloan Foundation. Sloan Fellowships honor early-career researchers whose achievements mark them among the next generation of scientific leaders. Each fellow will receive $75,000 to apply toward research endeavors.

New Project Coordination Unit Created to Improve Processes, Outcomes

WaNPRC Director Deb Fuller has announced the formation of a new Project Coordination Unit (PCU) that will assists with managing both new and existing research studies and that aims to improve communication and collaboration within the center as well as with affiliates.

That unit has already started tweaking processes, including managing the way new projects start. You’ll find more information on the process here.

Collaboration can improve in ways that make work life more clear and less frenetic for researchers and veterinarians alike. While the PCU team is in the early stages of creating ways to improve processes, one first step is assigning a project coordinator to each research project who can provide transparency and assistance to researchers. That coordinator will shepherd researchers through the whole process to avoid things like surprise timelines or preventable delays.

The coordinator will also help research teams with accessing additional resources, including equipment and connections with both internal and external collaborators.

Not only will the PCU focus on improving the experience for researchers at the center and success of research studies, it aims to improve the wellbeing for the people working to take care of our animals. The pursuit of transparency can improve that experience by ensuring that research objectives, clinical best practices, and BMS goals all align.

Until the team can build out processes, researchers or others with requests or questions can contact the Project Coordination Unit at: u_wanprc_pcprojects@uw.edu

Chlamydia Research Offers Hope for Global Health Solution

Chlamydia is one of the most widespread infectious diseases in the world, and it is remarkably difficult to prevent its spread. However, Dr. Kevin Hybiske, microbiologist and professor at the University of Washington in infectious diseases, microbiology and global health, offers new hope in collaboration with the Washington National Primate Research Center.

In his lab, Dr. Hybiske is unraveling the complex ways this pathogen manipulates human cells to spread and evade the immune system. By understanding these mechanisms, his team aims to develop innovative therapies that could one day lead to better treatments and, ultimately, a reduction in the global health burden caused by this disease.

“Anecdotally, it’s probably one of the oldest bacterial pathogens of multicellular hosts,” Dr Hybiske said. “We study it because we still don’t understand the processes it uses to infect cells (and thus people), and we need to better understand that to so we can improve our ability to treat it.”

According to the World Health Organization, there were more than 128 million new cases of this sexually transmitted infection (STI) in 2020. And before COVID, it was the most reported infection in the United States.

While Chlamydia can be easily treated with antibiotics, there is no preventative vaccine, and people infected with it often have no symptoms. These factors contribute to the high prevalence of Chlamydia in the population, disproportionally affecting women and people with limited access to medical screenings or treatment. If left undiagnosed and untreated, chlamydia can cause serious problems, including pelvic inflammatory disease and an increased risk of infertility and ectopic pregnancy.

Dr Hybiske’s lab is interested in studying the key steps involved with the development of the disease, in part, by creating “mutants” of chlamydia to learn how one mutant does its job of entering and exiting cells so that it can propagate.

“A big part of my lab is in the business of making Chlamydia mutants,” he said. “We’re among the best in the world at that. We use this strategy to figure out what’s important” in the ways chlamydia infects and impacts humans.

“Microbiologists make mutants and figure out what processes they can no longer do and trace the facts to a gene that’s been disrupted. And that’s how you figure out how a pathogen does what it needs to do. Whether divide, or attach, or kill a host cell,” he said. “Until about 10 years ago people who studied chlamydia couldn’t do that.”

A major hurdle to studying this pathogen is that, unlike some other bacteria, chlamydia requires a mammalian host and cannot be grown in a dish. Which is where WaNPRC comes in.

“I have had long professional relationships with investigators at UW who had established the chlamydia infection model in macaques. They’re the best in the world at it,” he said.

“This research is the kind of thing that can only be done in the circumstances that exist at WaNPRC because of the combination of collaborators, and the teams who care for the monkeys,” he said. “This is the basic science we’ve only recently been able to do, and we’re among the best. We have small libraries of mutants that no one else has, and which we are eagerly hoping to test in relevant models. Our partnership with the WaNPRC allow us to experiment and test in ways that’s never been done.”

Hybiske and his team are keenly aware of the ethical considerations surrounding primate research and take steps to ensure that their work is responsible and beneficial. In a recent pilot study, Hybiske explored the vaccine potential of a new genetically attenuated mutant of Chlamydia and found that exposing monkeys to this vaccine strain was safe and led to immunity against challenge with a pathogenic Chlamydia strain. This type of responsible research is respectful of animal well-being and health and also has the potential to lead to promising advances for addressing human Chlamydia infections. He hopes to receive a grant to pursue this vaccine development further.

The World Health Organization is working to reduce the global burden of sexually transmitted infections like chlamydia, aiming for a 50% reduction in new cases of chlamydia by 2030. “My work slides into that,” Hybiske said. “I am not someone who normally thinks about vaccine design, my work has mostly been focused on figuring out Chlamydia’s deep molecular secrets.” And the secret could be connected to creating a mutant of chlamydia with special properties that could be beneficial in a vaccine.

“There’s a well-trod path to vaccine development, and we are at the beginning,” he said. “We’re doing the necessary next steps to see what happens. See where that takes it. Even if this strain doesn’t become a vaccine home run, we are poised to learn a great deal about the primate’s immune response to a Chlamydia vaccine, and this will certainly aid other people who are trying to make vaccines. If we are lucky, one of these vaccine candidates will work great and have an impact on public health.”

O’Connor Earns Faculty Appointment

Congratulations to Dr Megan O’Connor on her appointment as Assistant Professor to the Department of Laboratory Medicine and Pathology at the University of Washington!

Megan, a Core Scientist at WaNPRC in the Infectious Disease and Translational Medicine Unit (ITDM) and Research Assistant Professor in the Department of Microbiology at UW, uses preclinical models to study HIV viral co-infections, with a particular emphasis on how in vivo immunosuppression shapes viral pathogenesis, host immunity, the microbiome, and response to vaccination. Ultimately, her goal is to improve treatment and vaccine strategies for people living with HIV and other immunocompromised individuals. Through this research program, she aims to uncover new insights into immune system dynamics and inform the development of more effective therapeutic interventions for a broad range of infectious diseases.

Megan first became interested in academic research during a high school internship at the Oregon National Primate Research Center, under the mentorship of Drs. Steven Kohama and Martha Neuringer. “Having an independent laboratory is something I’ve been working towards since I started research 20 years ago! It’s very exciting!” she said. She is looking forward to growing her scientific program, expanding her collaborations and professional friendships, and is deeply committed to training the next generation of scientists.

She completed her bachelor’s degree from the University of California, Berkeley. She found her passion for studying infectious diseases at the Vaccine and Gene Therapy Institute (VGTI) at Oregon Health and Sciences University. And she received her PhD in Immunology, under the mentorship of Dr. William Green, at the Geisel School of Medicine at Dartmouth, where she studied innate immune mechanisms contributing to LP-BM5 murine retroviral pathogenesis and immunodeficiency. She completed her postdoctoral training in the laboratory of Dr. Deborah Fuller at the University of Washington and evaluated pre-clinical nucleic acid vaccines against HIV, ZIKV, HBV, and SARS-CoV-2.

She enjoys spending quality time with her husband and 2 young daughters, and in her free time you’ll find her cooking, battling it out in board games, or staying active with running and hiking adventures.

She will start her new role on Feb 1.

The Cost of Extremist Attacks on Scientific Research

One tool extremist groups use to disrupt scientific research is to misuse government transparency laws, like the federal Freedom of Information Act (FOIA), or local public records laws. This is done to exploit public access in a dishonest attempt to misrepresent research so extremists can generate controversy and use that to fuel their fundraising efforts—all while wasting taxpayer money and distracting from the important work being done. These tactics are an abuse of the system that is meant to promote openness, not stifle science.

One of the latest efforts to undermine the scientific community came in the form of 775 FOIA requests filed with the USDA Animal and Plant Health Inspection Service (APHIS) in the first half of 2024, according to a report by Americans for Medical Progress (AMP). While the specific facilities targeted by these requests ranged from zoos to aquariums to agricultural operations, the issue is clear: extremists are weaponizing public records laws to create false narratives and fuel outrage.

At the Washington National Primate Research Center (WaNPRC), we are no strangers to this tactic. Since January of 2024 alone, we’ve received 23 public records requests (PRRs)—most of them from extremist groups. These groups take advantage of Washington state’s open records laws to request a wide range of documents – using the information not to better understand research, but to manipulate it, creating fodder for protests and fundraising campaigns.

Let me be clear: WaNPRC is committed to openness. We are overseen by an animal care and use committee that supports animal welfare and ensures we comply with federal regulations. All animal projects are reviewed and approved before they can begin. And we provide detailed reports on everything from our research protocols to any errors that may arise and how we address them. But there’s an obvious and troubling pattern to extremists’ requests: They consume valuable time and resources—time that could be better spent advancing science—while giving extremists ammunition that they use to misrepresent our work.

One telling example of these fishing expeditions came when a recent PRR requested every photo taken inside WaNPRC over a two-year period. Our staff painstakingly gathered over 700 images, because it’s the law, and because we have nothing to hide. But the reality is, these kinds of requests aren’t in the public interest. They’re nothing more than a tool for extremists to craft misleading narratives that misrepresent the work we do.

Take, for example, our tissue distribution program, which supports the 3Rs. Following humane euthanasia, this program serves as a vital resource, providing tissues to support multiple projects. The tissues from one animal can be used to answer questions regarding many different scientific questions. We strive to replace animal testing with alternative methods whenever possible, reduce the number of animals needed, and refine our techniques to minimize animal stress.

Without context, however, photos of these procedures can be easily misrepresented. For example, a photo of an animal technician holding a surgical instrument, or steadying an animal, could appear disturbing if viewed without context. So might a dentist photographed holding a needle or forceps, or a brain surgeon holding a drill. The fact is our work aims to improve both animal welfare and human health. But extremists don’t share this perspective. Instead, they use images out of context to generate shock value and rally their supporters—often for fundraising purposes.

This abuse of FOIA and public records laws doesn’t just waste time; it also wastes taxpayer money. Responding to these fishing expeditions requires significant staff time, and there’s often little to show for it other than more misinformation. And while these extremist groups claim to be working for the welfare of animals, their actions have the opposite effect: they disrupt scientific research, mislead the public, and hinder the development of life-saving treatments for both animals and people. They also make it harder to recruit the very people who take care of animals at the high standards of care we uphold.

One recent victory in defending scientific research against extremist misinformation came from the U.S. Fish and Wildlife Service (USFWS), which rejected a petition from People for the Ethical Treatment of Animals (PETA) to list long-tailed macaques, also known as Cynomolgus macaque (LTM) under the Endangered Species Act.

In a decision issued in October, the USFWS found that PETA’s petition “did not present credible information to support impacts to LTM populations or the species as a whole.” This decision is a victory not just for scientific research but for the integrity of the system that allows for public input and transparency. The USFWS saw through PETA’s petition and understood that extremist groups are often more interested in promoting political agendas than in advancing genuine animal welfare or scientific progress. You can read the USFWS findings here and see for yourself.

Support Science, Not Extremism

At WaNPRC, we support openness. We believe in the public’s right to know how taxpayer dollars are spent and the importance of open government. It’s also clear that some extremist groups are abusing these laws to advance their own agendas, not to protect animals or promote scientific progress.

These groups create controversy where none exists, misrepresent our work, and ultimately do more harm than good. Their attacks do not stop science, but they do waste time, money, and resources that could be better spent advancing human health and animal welfare.

As long as fundraising remains their primary goal, these attacks will continue. But the more the public and policymakers recognize these tactics for what they are—misguided, costly, and ultimately counterproductive—the sooner we can create an environment where we can all work together toward common goals.

WaNPRC Highlights at NHP AIDS Conference

The 41^st Annual symposium on Nonhuman Primate Models for AIDS is under way in New Orleans this week, and the Washington National Primate Research center is well-represented by both speakers and attendees.

The WaNPRC contingent consists of session speakers, poster presenters and attendees. “This meeting is the only one of its kind in the world,” said Dr. Kristina Adams Waldorf, Interim Director of Research at WaNPRC. “The symposium includes research presentations on HIV, HIV-like viruses, such as SARS-CoV-2, influenza, Zika, Valley Fever and others that nonhuman primates serve as a close model to human infection that can be used in nonhuman primates to model AIDS, With 38 million people currently estimated to be living with HIV worldwide, the need to develop better treatments and interventions to prevent and/or cure HIV infection remains critical.”

Dr. Chris Peterson, a WaNPRC Affiliate with the Fred Hutch Cancer Center, is presenting on research targeting an HIV-like virus in macaques with (chimeric antigen receptor) CAR-T cells that are specific for a viral protein. “A major challenge to cure HIV is that antiretroviral therapy suppresses the virus to the point that it is essentially invisible to the immune system, but is not curative,” Dr. Peterson said. “What we’re trying to do here is extend how long our CAR T-cells work in the body, so that they more time to locate these rare, infected target cells, leading to a cure.”

Also presenting is Professor Donald Sodora, PhD, Adjunct Professor of Global Health, on the impacts of an HIV-like virus on the liver of nonhuman primates.

WaNPRC was important in establishing the symposium which began as a way for all seven NPRCs to meet and discuss research on the AIDS pandemic using nonhuman primates. At the time, primates were the only animal model that could be infected with a virus that was similar to HIV and develop AIDS symptoms.

“Back then, the NPRCs had been around for about 10-15 years, and were mostly focused on neurosciences,” said WaNPRC Director Dr. Deb Fuller. “But several scientists in infectious diseases at WaNPRC and others at Tulane first showed that old world monkeys (rhesus macaques at Tulane and pigtails at WaNPRC) could be infected with SIV. This launched a huge influx of funding from the NIH into the NPRCs to lead research in NHPs on AIDS and to this date, NIAID is still a major contributor to the P51 and U42 center grants that each NPRC is funded under to support their robust AIDS research programs.”

and has become a meeting place for a large number of scientists and Early-Stage Investigators, many of whom will give their first presentations.

One WaNPRC presenter is Orlando Cervantes, a graduate student in the Adams Waldorf Laboratory. He’ll be sharing his findings on how pandemic influenza infections during the third trimester of pregnancy damage the placenta by provoking a strong immune response.

“Scientists and doctors still don’t fully grasp the ways influenza infection can lead to stillbirth or preterm birth in pregnant women,” said Orlando. “By better understanding the placenta’s response to a maternal influenza infection, we can get clues on how that can compromise placental integrity and hurt the developing fetus. I’m very excited to share these findings because they can encourage other scientists to begin using NHP models to study the interaction between pregnancy and other illnesses/infections.”

The symposium follows on the heels of the HIV Vaccine Trials Network Early Stage Investigator conference, which also took place at the same location. The conference aimed at early-stage investigators (ESIs) specializing in translational HIV research in non-human primates (NHPs) and clinical HIV and TB research is set to offer participants valuable opportunities for professional growth. Attendees will gain insights into their potential contributions to the field and receive support in achieving key career milestones. Previous participants have reported that the event enhanced their skills and knowledge, while also providing a platform for building new collaborations.

Several WaNPRC researchers will have posters at the meeting including Director Deborah Fuller, Associate Director of Research Dr. Kristina Adams Waldorf, and Dr. Charlotte Hotchkiss, D.V.M, Ph.D. As well as the following:

Megan O’Connor – HIV/COVID-19 and/or HIV/ZIKV co-infection
Chris Peterson – HIV
Serena deBanco – HIV (scholarship recipient)
Megan Fredericks – Valley Fever

The symposium concludes October 25.

New Light Helps Reset Your Internal Clock: “Thank a Monkey”

As we move deeper into fall and the hours of daylight dwindle, a trio of researchers from the same family has worked together to create new technology that helps humans improve our health and our moods by managing our circadian rhythms. And they say we can thank research monkeys for it.

In new research from professors Jay and Maureen Neitz of the UW Department of Ophthalmology, and their youngest daughter Alex (who was a graduate research assistant at UW and is now a postdoctoral researcher at the University of California San Diego) helped show that, an LED light that emits alternating wavelengths of orange and blue light helped boost melatonin levels in a group of study participants, shifting their “internal clocks” to align how our body’s supposed to act during different times of day.

The findings, published in the Journal of Biological Rhythms, show that the alternating wavelengths can influence circadian rhythms, an effective approach to counteract seasonal affective disorder (SAD), among other maladies.

A host of health and mood problems are attributed to out-of-sync circadian rhythms, Jay Neitz says. The result is “social jet lag” that occurs during seasonal changes and a lack of exposure to natural light, not to mention night jobs and international travel.

“In extreme cases what this being not synchronized has been linked to diabetes and cancer and all sorts of problems,” he said. “At the very least, people just aren’t at their best. They don’t feel great because their internal clock isn’t set right. Theirs’s huge interest in this kind of thing.”

The Neitzes designed an experiment using light that alternated between short- and long-wavelength components that advanced the circadian phase by an average of almost an hour and a half.

And it’s led to the development of products that produce these alternating blue/orange wavelengths. Called “TUO Circadian Smart Products,” the line consists of an LED lightbulb and various lamps, which can be managed by a smartphone app.

All this from the trio who mesh work and life and always have.

“There’s a lot of talk about work life balance,” said Jay. “Our work and lives have just been one thing. We work all the time, and we have two daughters. Our younger daughter, Alex, started working in our lab as a child.”

“It wasn’t like this started in grad school it was a gradual process,” Alex said. “In grad school I was interested in circadian rhythms, and I went to grad school immediately after undergrad.”

Like mother, like daughter. Maureen and Alex are both molecular biologists who wound up interested in studying vision and the nonhuman primate model.

Jay credits NHP research stemming from a grant that helped Maureen obtain an electron microscope that enabled researchers to build a complete look at the retina that was the foundation for research that led to the Tho light. So none of it would have happened without NHP research.

“There are things about the way our eyes work and how they communicate with the central parts of our brain that are unique to primates,” Jay said, recalling contributions of WaNPRC’s Tissue Distribution Program. “Because of that we got preservation of microdetails of all cells in the retina that could never be gotten from a human. We believe what we’re seeing in the NHP model is exactly like what happens in a human. There’s just no other example like this.”

New Director Outlines Vision for WaNPRC

Dr Deborah Fuller

In a world that is constantly changing, I wanted my first Director’s blog post to serve as a way of addressing change for WaNPRC and the people and primates we serve. I’d like all our readers to know what to expect as WaNPRC embarks on its next chapter.

First, a note of thanks to all past directors of the center. They have led the center as researchers here made multiple discoveries that have had a historic impact on global human health. I’ve had the pleasure of working with several of them, and I’m honored to now take my place at the helm.

Having spent the last 14 years working at the Center and having co-founded a biomedical technology company I bring a combination of science and business savvy to this role. And while I applaud our previous leadership, I have a lofty vision of my own I hope to achieve.

I want to make WaNPRC the top primate research center in the U.S., and the top institute in the world for nonhuman primate research. Sounds ambitious, but I have a six-pronged plan to get us there.

Affirm our identity

Build and expand our identity through interdisciplinary consortia and collaborations

Enhance communications between research units and between researchers & veterinary staff

Implement strategies for long-term sustainability

Support a 3Rs culture: Respect, Restraint, Responsibility

Increase our visibility

I’m not sure people are aware of just how important WaNPRC is to research in gene therapy, infectious disease, neuroscience and global conservation. Just in the last year, we supported 126 grants totaling $118 million in funding. We have more than 150 employees, and we support nearly the same number of collaborating scientists nationwide. And we are the only NPRC that breeds pigtail macaques, the best NHP model for a wide range of vital areas of research that has led to breakthroughs. For example, the pigtail macaque is the closest species to model pregnant women, and research in this model at WaNPRC led to the first insights into how Zika virus and other infectious disease cause fetal injury and is paving the way toward new innovations to protect women from sexually transmitted diseases.

Our research has also revealed new insights into the causes of neurological, genetic, cardiovascular and infectious diseases, and we are turning these discoveries into cures for people living with AIDS, spinal injuries, cancer, color blindness, blood disorders and cardiovascular disease. We are also at the forefront in developing new vaccines and immunotherapies for malaria, HIV, influenza, SARS-CoV-2 and Valley Fever, a fungal disease that is rapidly spreading due to climate change.

Our outstanding animal behaviorists and veterinary teams are critical to the success of this research. Their ability to innovate and refine new techniques has improved our research, animal breeding and care. We are also the only NPRC with a worldwide primate conservation and education program that has gained international recognition for its cutting-edge work in understanding nonhuman primates in the natural habitat and their interface with humans.

I believe that the most innovative ideas occur at the intersection of different disciplines. My aim is to build on our track record and provide our outstanding faculty with new opportunities to collaborate to bridge scientific discipline, combine our research strengths and spur innovation. To that end, I announced last month a $150,000 funding opportunity that will require a collaboration between two or more researchers working in distinct research disciplines. Stay tuned for an announcement about this opportunity in November, concurrent with our annual P51 pilot project initiative.

While this is going on, we’re also already working on a shift in culture that improves collaboration between our researchers and animal care teams to benefit both animals and the research they support. The tight job market has affected WaNPRC the same way it has other industries. You’ll be seeing a more aggressive recruiting campaign and new opportunities for our veterinary teams to lead and collaborate with our researchers in projects aimed at developing novel veterinary procedures and new concepts to enhance our animal behavior, breeding and care,

In the longer term, you’ll see us landing opportunities to improve our financial outlook by seeking partnerships and funding sources that improve revenue and increase efficiency while reducing our costs. Seattle is a growing hub for biotechnology and in parallel, we are expanding our portfolio of translational research studies and capabilities to support a growing need for preclinical research in nonhuman primates that provide a critical bridge to close the gap between biomedical breakthroughs at the bench and human clinical trials. For example, research at our primate center is helping HDT Bio, Orlance, Inc., Sana Biotechnology and Umoja Biopharma advance their novel innovations for new vaccines, stem cell, and cancer therapies to human clinical trials.

There’s also something we’re going to stop doing: We’re not going to shrink from the opportunity to tout the successes we have. We’re constantly bombarded by misinformation and lies put out by animal rights extremists. But we’re not going to let them tell our story, and we’re not going to let bullying and threats affect our work. So, expect to see more in this spot about the research we do and how we’re improving human health and animal welfare at the same time.

Come visit this site every month. You’re going to hear from me and other leaders at WaNPRC about all these topics as we work to bring to life that ambitious vision.

It’s a privilege to have the opportunity to lead WaNPRC in these efforts. I am looking forward to seeing the progress we make towards these goals.

Increased Support for NHP Neuroscience Research “Critical” to Advance Human Health

Increasing investment and support for neuroscience research involving monkeys is critical to realize our hope for advancing human health and reducing suffering for millions of people confronting diseases like Alzheimer’s, bipolar dis- order, depression, anxiety, schizophrenia. So argues Dr. Michele A. Basso, core scientist in the Neuroscience unit of the Washington National Primate Center.

Portrait of Dr Basso — Dr Michele A. Basso is a core scientist in the Neuroscience Unit of WaNPRC

Basso and partners with the Simian Collective penned an urgent commentary in the Journal of Neuroscience this month, framing the nonhuman primate neuroscience as one of “peril or possibilities.”

In the piece, Basso notes that the cost to the United State to treat neurological and neuropsychiatric disorders at more than $1 trillion annually. And that monkeys will be necessary for the discovery, development, and testing of treatments because monkeys share traits with humans that other testing animals lack.

A big hurdle to progress is a shortage of monkeys for research, highlighted in a 2023 report from the National Academy of Sciences, Engineering, and Medicine. The shortage, and subsequent high costs, prevents scientists from advancing treatments.

“To ensure a sustainable resource of non- human primates for biomedical research, including and especially in neuroscience, the US must engage in domestic capacity building,” Basso argues.

And while new approach methods are pursued, she writes, “developing treatments and cures for Alzheimer’s disease and related neurodegenerative diseases, and the many neuropsychiatric illnesses, will all ultimately require an understanding of the brains of primates and perhaps the immune system, which, like the brain, is significantly more like humans in monkeys than in rodents.”

Read the full text in the Journal of Neuroscience. Explore the Neuroscience unit at WaNPRC.

This Guest Director’s Blog is by Mark Walton, PhD. He is a senior research scientist at WaNPRC in the Neuroscience core. We welcomed his timely thoughts in a climate in which it’s valuable to understand the importance of animal research in advancing human and animal health.

This Guest Director’s Blog is by Mark Walton, PhD.
He is a senior research scientist at WaNPRC in the Neuroscience core. We welcomed his timely thoughts in a climate in which it’s valuable to understand the importance of animal research in advancing human and animal health.